Metrology for metalloproteins-where are we now, where are we heading?

被引:21
|
作者
Swart, Claudia [1 ]
机构
[1] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany
关键词
Clinical/biomedical analysis; Metalloproteins; Reference materials; Reference measurement procedures; CARBOHYDRATE-DEFICIENT TRANSFERRIN; C-REACTIVE PROTEIN; DILUTION-MASS-SPECTROMETRY; HPLC-ICP-MS; INTERNATIONAL REFERENCE PREPARATION; BIOINORGANIC SPECIATION ANALYSIS; REFERENCE MATERIAL-470 CRM-470; STANDARD REFERENCE MATERIAL; HUMAN SERUM TRANSFERRIN; HUMAN BRAIN PROTEINS;
D O I
10.1007/s00216-013-6933-y
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The use of the amount of certain proteins in biological samples as markers for distinguishing between a healthy and a diseased state has become increasingly important in clinical diagnosis. As about 30 % of all proteins contain metals in one form or another, either as a cofactor or covalently bound as part of the protein, some of these proteins are regularly analyzed in clinical laboratories. With the increasing number of measurements of those proteins performed all over the world, the necessity of obtaining reliable and comparable results is becoming a focal point for scientists and politicians. Directives such as the EC directive covering in vitro diagnostic medical devices (Directive 98/79/EC) and standards such as EN ISO 17511:2003 demand the traceability of the results obtained for analytes in samples of human origin. However, no reference measurement procedures with results traceable to the SI exist for many metalloproteins. In this article, the situation for a few important metalloproteins, such as hemoglobin, transferrin, superoxide dismutase, ceruloplasmin, and C-reactive protein, for which specific efforts have been made in recent years to achieve comparable and traceable results worldwide, is discussed. These proteins also serve as examples of the difficulties scientists face when they wish to quantify proteins and the pitfalls they should avoid to achieve reliable results.
引用
收藏
页码:5697 / 5723
页数:27
相关论文
共 50 条
  • [1] Metrology for metalloproteins—where are we now, where are we heading?
    Claudia Swart
    Analytical and Bioanalytical Chemistry, 2013, 405 : 5697 - 5723
  • [2] Echocardiography: where are we now and where are we heading?
    Picard, MH
    WHAT'S NEW IN CARDIOVASCULAR IMAGING?, 1998, 204 : 323 - 331
  • [3] Naturopathy in Australia: Where are we now? Where are we heading?
    Ooi, Soo Liang
    McLean, Lisa
    Pak, Sok Cheon
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2018, 33 : 27 - 35
  • [4] Amyloidosis-Where Are We Now and Where Are We Heading?
    Picken, Maria M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (04) : 545 - 551
  • [5] Aligner biomechanics: Where we are now and where we are heading for
    Castroflorio, Tommaso
    Parrini, Simone
    Rossini, Gabriele
    JOURNAL OF THE WORLD FEDERATION OF ORTHODONTISTS, 2024, 13 (02) : 57 - 64
  • [6] Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?
    Mazzanti, Andrea
    Kukavica, Deni
    Trancuccio, Alessandro
    Scilabra, Gabriele G.
    Coppini, Lucia
    Pergola, Valerio
    Tempo, Erika
    Pili, Gianluca
    Napolitano, Carlo
    Priori, Silvia G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2025, 27 : i98 - i102
  • [7] Women entrepreneurship in China: where are we now and where are we heading
    Cooke, Fang Lee
    Xiao, Mengtian
    HUMAN RESOURCE DEVELOPMENT INTERNATIONAL, 2021, 24 (01) : 104 - 121
  • [8] Zirconia dental implants: where are we now, and where are we heading?
    Cionca, Norbert
    Hashim, Dena
    Mombelli, Andrea
    PERIODONTOLOGY 2000, 2017, 73 (01) : 241 - 258
  • [9] Minimally Invasive THA: Where Are We Now and Where Are We Heading?
    Eskelinen, Antti
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2017, 99 (20):
  • [10] Serverless Computing-Where Are We Now, and Where Are We Heading?
    Taibi, Davide
    Spillner, Josef
    Wawruch, Konrad
    IEEE SOFTWARE, 2021, 38 (01) : 25 - 31